<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=1502033&amp;fmt=gif">
'Outstanding' CQC Rating for Everlight's brand of Teleradiology, Nov 21, 2019

cta-dummy-blog-post_2

Ape re nimodit aspero elia consece

Ape re nimodit aspero elia consece prorume magnam, sed quo ipidunt exernatia ex ea quam quidere dis archit lab is in pos quatiumquia sincius alibus autatumquam ratquo maiorest et que sus, nus dolent. Milia plabor mintem quis et lam, quame net ventibust, ex eicimaionse pa dolupic tionsen ditat etre da estes. Autatumquam ratquo maiorest et que sus, nus dolent. Milia plabor mintem quis et lam, quame net x ea quam quidere dis archit lab.

Register now

Subscribe to our blog

Everlight Radiology was awarded a 2016 Australian Growth Company Award for Health and Life Sciences Growth Company of the Year.

Written by Everlight News Desk

on Sep 14, 2016

Launched in 2012, the Australian Growth Company Awards celebrate excellence in the mid-market in Australia. Companies in the Australian Growth Company Award for Health and Life Sciences Growth Company of the Year category must be Australian, have been in business for a minimum of two years and demonstrate a market share in the mid-market range of $15 million to $500 million. Entrants in this category are assessed on their high rates of growth, as well as innovation, integrity, contribution to community and sustainable growth.

Given the large number of quality entrants in this category, we are proud and grateful to our outstanding team and all stakeholders who helped make this happen.

The award ceremony, held in Sydney on 27 October 2016, marked the culmination of the annual Australian Growth Company Awards programme.